Hyperphagia clinical trials
The registry lists 39 studies for Hyperphagia across more than 10 countries. 4 are recruiting or about to start. 9 of them are mainly about Hyperphagia (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-30. Counting its narrower condition Bulimia too: 207 studies, 37 open.
Get an email when these change. Save the Hyperphagia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Oregon Research Institute (2) · University of California, San Diego (2) · Aardvark Therapeutics, Inc. (2) · Corporacion Parc Tauli (2) · Yale University (2) · Laval University (1) · Temple University (1) · University of British Columbia (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The study
- Dec 2026A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder · Massachusetts General Hospital
Who these studies take
Of the 4 Hyperphagia studies recruiting now, 1 (25%) set no upper age limit and 3 (75%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (25%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 4 (100%) | 4 (100%) |
| 30 | 4 (100%) | 4 (100%) |
| 40 | 4 (100%) | 4 (100%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 3 (75%) | 3 (75%) |
| 75 | 1 (25%) | 1 (25%) |
| 85 | 1 (25%) | 1 (25%) |
Across all 39 studies, recruiting or not: 74% stop at 75 or younger and 69% at 65; 38% take children; 13% are for women only and 5% for men only; 44% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Hyperphagia studies take
Of 16 interventional studies with no phase under Hyperphagia, half reached primary completion within 35 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 35 mo17–54 · 16 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting1
- Exploratory Study of Sensory Profile and Coping Strategies in Eating DisordersOct 30, 2026NCT07031037
Stopped1
- Gastric US in ICU PatientWithdrawnOct 20, 2026NCT05526105
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 39 of 39. search them.
- Exploratory Study of Sensory Profile and Coping Strategies in Eating DisordersRecruitingNCT070310371 country
- fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional OvereatingRecruitingNCT05200182Not applicable1 country
- A Study of the Effects of Oxytocin in Adults With Binge-eating DisorderRecruitingNCT05664516Phase 21 country
- Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi SyndromeRecruitingNCT06720571Not applicable1 country
- Impact of Bright Light Therapy on Prader-Willi SyndromeActive, not recruitingNCT05939453Not applicable1 country
- Biobehavioral Reward Responses Associated With Consumption of Nutritionally Diverse Ultra-Processed FoodsActive, not recruitingNCT05437809Not applicable1 country
- The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) TrialTerminatedNCT07197034Phase 35 countries
- ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialTerminatedNCT06828861Phase 35 countries
- Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie IntakeCompletedNCT06556277Not applicable1 country
- A Study of Setmelanotide in Patients With Prader-Willi SyndromeActive, not recruitingNCT06772597Phase 21 country
- Determine if Human Infant Weight Gain Can be Modulated to Prevent ObesityWithdrawnNCT04526860Not applicable1 country
- Early Genetic Identification of ObesityActive, not recruitingNCT062390641 country
- EXOMIND (BTL-995) for Reduction of Binge-eatingCompletedNCT06910592Not applicable1 country
- Problematic Decision-Making and Adolescent Weight LossCompletedNCT04848532Not applicable1 country
- Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With ObesityCompletedNCT06242535Early Phase 11 country
- Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic ImpactCompletedNCT069003351 country
- Effect of Deep Propioceptive Stimulation in Prader-Willi SyndromeCompletedNCT05044000Not applicable1 country
- Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi SyndromeCompletedNCT03197662Phase 21 country
- Computerized Response Training Obesity TreatmentCompletedNCT03375853Not applicable1 country
- CHARGE: Controlling Hunger and ReGulating EatingCompletedNCT03678766Not applicable1 country
- Fiber Intervention on Gut Microbiota in Children With Prader-Willi SyndromeCompletedNCT04150991Not applicable1 country
- The Play With Me StudyCompletedNCT04280198Not applicable1 country
- Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi SyndromeCompletedNCT02629991Phase 21 country
- Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi SyndromeTerminatedNCT03790865Phase 2/38 countries
- Testing a Brief Mindful Eating ProgramCompletedNCT04531436Not applicable1 country
- Body Composition Changes During Overfeeding Plus Resistance TrainingCompletedNCT04069351Not applicable1 country
- Treatment for Obesity and Binge Eating DisorderCompletedNCT00537758Not applicable1 country
- Food Response Training for Binge EatingTerminatedNCT02817412Not applicable1 country
- Sense2Stop:Mobile Sensor Data to KnowledgeCompletedNCT03184389Not applicable1 country
- Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi SyndromeCompletedNCT01863017Not applicable1 country
- Evaluation of Art-therapy on Alexithymia in Patients Suffering From Anorexia Nervosa and From BulimiaStatus unknownNCT035244431 country
- Stepped Care Treatment for Binge-EatingCompletedNCT00965705Not applicable1 country
- Family Based Treatment for Weight Loss With Breakfast PrescriptionCompletedNCT02467036Not applicable1 country
- Effects of Noninvasive Brain Stimulation on Brain Activity and AppetiteStatus unknownNCT02758262Not applicable1 country
- The Impact of Snacks Which Vary Nutritionally in Their Satiating Potential on Measures of Appetite ControlCompletedNCT02480582Not applicable
- Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) TrainingCompletedNCT01721499Phase 11 country
- Location Specific Differences in Intestinal Brake ActivationCompletedNCT02500069Not applicable1 country
- Guided Self-Help Treatment for Binge Eating DisorderCompletedNCT00158340Not applicable1 country
- Prader-Willi Syndrome and AppetiteTerminatedNCT00175305Phase 31 country